SNO 2020: Lapatinib + WBRT/SRS Trends Toward Improvement of Brain Metastases From HER2+ Breast Cancer
The drug crosses the blood-brain barrier and demonstrates activity against brain metastases.
Sign in to PracticeUpdate
Only registered members have full access to PracticeUpdate content.
Brain Cancer Center of Excellence
Visit our Brain Cancer Center of Excellence for additional, in-depth coverage.